Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel – the first allogeneic stem cell therapy to be approved for use across the European Union – for use in Crohn’s patients
read moreThe number of children and young people being treated for type II diabetes has leapt by around 40 percent in just four years to more than 700 cases, NHS data show. More: Cases of type II diabetes surge in under-25s
read moreConfusion about cancer symptoms among workers could be leading to delayed diagnoses and irregular self-examinations, suggests new research by Bupa UK. More: Widespread confusion about cancer symptoms delaying diagnoses Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals